- Relevium Technologies (TSXV:RLV) has successfully completed its first delivery of hand sanitiser to customers in the US
- Through this delivery, the company has started fulfilling orders which it received in mid-April
- Relevium is working to ramp up its capacity, speed of supply, and product format offering as it continues fulfilling orders
- The company expects demand for sanitiser to remain strong through 2021 and has applied to sell it on online marketplaces
- Relevium Technologies (RLV) remains unchanged today and is trading at C$0.04 per share
Relevium Technologies (TSXV:RLV) has successfully completed its first delivery of hand sanitiser to customers in the US.
The company first announced its intentions to commercialise a line of Bioganix hand sanitisers in early April. This was in response to a sudden spike in demand, caused by health fears surrounding the COVID-19 pandemic.
By April 15, Relevium had received initial orders for the sanitiser totalling C$250,000. This prompted the company to scale up operations in order to meet the unprecedented demand.
Now, Relevium has finally started fulfilling the orders which it received in mid-April from retail customers in the US. The company will continue to fulfil orders over the next 15 days as it builds its inventory levels.
Relevium’s CEO, Aurelio Useche, commented on market conditions for sanitiser since the COVID-19 pandemic broke out.
“The combination of the unusually high demand created by COVID-19 and the scarcity of supply in the market created long lead times for some of the critical components, including alcohol and packaging supplies.
“These market conditions led to the appearance of cheap, non-compliant imported products, some of which have been recalled.
“We are extremely pleased to be able to provide to the market and begin the successful delivery of a premium and compliant product made in the US and Canada,” he said.
Relevium expects that demand for sanitisers will remain strong through 2021. While it continues fulfilling orders, the company hopes to ramp up its capacity, speed of supply, and product format offering.
The company is working to expand and customise the sanitiser product line. This would include introducing specific requirements for retailers, like co-branding, colouring, scents, etc.
Relevium is also working to expand its brick-and-mortar retail network, primarily in the US. Online, the hand sanitiser currently remains restricted on all major online platforms. The company has already applied for approval to sell its product on online marketplaces.
Relevium Technologies (RLV) remains unchanged today and is trading at C$0.04 per share at 1:54pm EDT.